Evidence map›Paper›PMID 34786018›Full record

ArticleTobacco induced diseases2021

Characteristics of and reasons for patients with chronic obstructive pulmonary disease to continue smoking, quit smoking, and switch to heated tobacco products.

Kuniaki Hirai, Akihiko Tanaka, Tetsuya Homma, Tomoko Kawahara, Naruhito Oda, Hatsuko Mikuni, Yoshitaka Uchida, Haruhisa Saito, Yosuke Fukuda, Akiko Fujiwara and 8 more

Abstract read
In one paragraph

Article in Tobacco induced diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Smoking cessation and vaccination.European respiratory review : an official journal of the European Respiratory Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Kuniaki HiraiDivision of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Akihiko TanakaDivision of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Tetsuya HommaDivision of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Tomoko KawaharaDivision of Respiratory Medicine, Department of Medicine, Yamanashi Red Cross Hospital, Yamanashi, Japan.
Naruhito OdaDivision of Respiratory Medicine, Department of Medicine, Yamanashi Red Cross Hospital, Yamanashi, Japan.
Hatsuko MikuniDivision of Respiratory Medicine, Department of Medicine, Kokuho Asahi Chuo Hospital, Chiba, Japan.
Yoshitaka UchidaDivision of Respiratory Medicine, Department of Medicine, Kokuho Asahi Chuo Hospital, Chiba, Japan.
Haruhisa SaitoDivision of Respiratory Medicine, Department of Medicine, Kokuho Asahi Chuo Hospital, Chiba, Japan.
Yosuke FukudaDivision of Respiratory Medicine, Department of Medicine, Ebara Hospital, Tokyo, Japan.
Akiko FujiwaraDivision of Respiratory Medicine, Department of Medicine, Odawara Municipal Hospital, Odawara, Japan.
Yoko SatoDivision of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Tomoki UnoDivision of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Hideki InoueDivision of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Shin OhtaDivision of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Fumihiro YamaguchiDivision of Respiratory Medicine, Department of Medicine, Showa University Fujigaoka Hospital, Fujigaoka, Japan.
Shintaro SuzukiDivision of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Tsukasa OhnishiDivision of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Hironori SagaraDivision of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSmoking is the leading cause of chronic obstructive pulmonary disease (COPD), and smoking cessation is the most effective treatment for patients with COPD. However, few studies have investigated the continuation/cessation of smoking and heated tobacco products (HTP) in patients with COPD. The objective of this study was to examine the characteristics of patients with COPD, those who are current smokers and those who switched from cigarettes to HTP, and to examine the reason for the continuation or cessation of smoking.

methodsThis multicenter, cross-sectional study included 411 outpatients with COPD. Data for this study were part of a study conducted for a comprehensive evaluation of the smoking status and clinical factors in patients with COPD and their families.

resultsLogistic regression analysis revealed that a younger age, longer duration of smoking, fewer daily cigarettes, and lower modified Medical Research Council (mMRC) dyspnea score, and a lower Simplified Nutritional Appetite Questionnaire (SNAQ) score for appetite, were characteristics of current smokers (age OR=0.94; duration of smoking OR=1.07; number of cigarettes per day OR=0.94; mMRC OR=0.68; SNAQ OR=0.83; p<0.05). The logistic regression analysis model showed that a younger age and higher education level were associated with the use of HTP (age OR=0.83; higher education level OR=4.63; p<0.05). Many of the current smokers displayed smoking behaviors that are not guaranteed to be safe, such as reducing smoking or switching to lighter cigarettes or HTP.

conclusionsPatients with COPD who continue smoking tended to have low appetite as well as smoking behaviors that are not guaranteed to be safe. Physicians should provide appropriate guidance to these patients on smoking cessation.

Indexed as

chronic obstructive pulmonary diseasecigarettesheated tobacco productssmoking

Identifiers

PMID34786018
PMCPMC8562318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.